Broadcast Date: March 23, 2023
Time: 8:00 am PT, 11:00 am ET, 16:00 CET
Today millions of patients suffer or die from diseases that will be treatable or even preventable tomorrow. For 200 years, biopharma has steadfastly produced medicines to address unmet medical needs. But in the last 20 years or so, the notion of ‘programmable medicines’ has emerged as a possibility to dramatically transform these production rates. And in the past few years, mRNA therapeutics have brought those possibilities to greater fruition.Yet, so far, too few of these have managed to produce programmable information molecule medicines. Why? What’s missing?
The answer lies in how to code the “to” the cell aspect. This is the missing link and, ironically, something that nature has been doing for millions of years as species from all kingdoms of life have evolved to communicate intercellularly. How to code the “to the cell” feature is the breakthrough biopharma has been waiting for.
In this GEN webinar, our distinguished guest, Dr. Guillaume Pfefer, CEO of Senda Biosciences, will share how to access the “chemical address code” from nature’s interspecies cellular communication—and how his organization’s machine learning-enabled platform is genuinely turning the crank to comprehensively program medicines for the very first time.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.
Produced with support from:
CEO, Senda Biosciences
Partner, Flagship Pioneering
The post Beyond mRNA Design to Truly Programmable Medicines appeared first on GEN – Genetic Engineering and Biotechnology News.
